Paradigm Biocapital Advisors LP

Q4 2021 13F Holdings Report, Stock Holdings

Signature - Title
David K. Kim - Chief Operating Officer and Chief Compliance Officer
Location
New York
Holdings as of
31 Dec 2021
Value $
$350,154,000
Num holdings
24
Filing time
14 Feb 2022, 08:40:10 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included MRTX, ASND, ZNTL, VRDN, and ARNA.
Next filing
Q1 2022 - 16 May 2022
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
David K. Kim Chief Operating Officer and Chief Compliance Officer New York, New York 14 Feb 2022